Literature DB >> 35990027

Retrospective Diagnosis of Pontocerebellar Hypoplasia Type 1B in a Family with Two Deceased Newborn Children.

Irena Bradinova1, Silvia Andonova1, Alexey Savov1.   

Abstract

Pontocerebellar hypoplasia type 1B is a severe autosomal recessive neurologic disorder characterized by a combination of cerebellar and spinal motor neuron degeneration beginning at birth. Pontocerebellar hypoplasia type 1B is caused by mutations in EXOSC3 gene. High prevalence of the p.Gly31Ala mutation was found recently, especially in the Roma ethnic minority. We present a young Bulgarian Roma family with two deceased newborn children manifesting severe neuromuscular disorder including severe muscle weakness, respiratory distress, and multiple joint contractures. Based on the clinical signs and family's population characteristics, DNA testing for the previously described EXOSC3 in Bulgarian Roma mutation c.92G > C; p.Gly31Ala was performed on blood samples of both parents and they were found to be heterozygous carriers. This finding indirectly confirmed the diagnosis of pontocerebellar hypoplasia type B in the deceased offspring. Knowledge of population-specific molecular bases of genetic conditions was the key to final diagnosis in the presented family. Designing of population-based clinical-genetic panels may be a powerful diagnostic tool for patients with such origin. Preconception carrier screening in high-risk population groups is a feasible option to discuss. Thieme. All rights reserved.

Entities:  

Keywords:  EXOSC3 gene ; Pontocerebellar hypoplasia type 1B; Roma population genetic diseases; spinal muscular atrophy

Year:  2020        PMID: 35990027      PMCID: PMC9385256          DOI: 10.1055/s-0040-1718536

Source DB:  PubMed          Journal:  J Pediatr Genet        ISSN: 2146-460X


  19 in total

1.  Cerebellar hypoplasia in Werdnig-Hoffmann disease.

Authors:  R M NORMAN
Journal:  Arch Dis Child       Date:  1961-02       Impact factor: 3.791

Review 2.  Pontocerebellar hypoplasia type 1 for the neuropediatrician: Genotype-phenotype correlations and diagnostic guidelines based on new cases and overview of the literature.

Authors:  I Ivanov; D Atkinson; I Litvinenko; L Angelova; S Andonova; H Mumdjiev; I Pacheva; M Panova; R Yordanova; V Belovejdov; A Petrova; M Bosheva; T Shmilev; A Savov; A Jordanova
Journal:  Eur J Paediatr Neurol       Date:  2018-04-03       Impact factor: 3.140

Review 3.  Infantile olivopontocerebellar atrophy with spinal muscular atrophy (infantile OPCA + SMA).

Authors:  S M Chou; E F Gilbert; R W Chun; R Laxova; G A Tuffli; R L Sufit; N Krassikot
Journal:  Clin Neuropathol       Date:  1990 Jan-Feb       Impact factor: 1.368

4.  Homozygous EXOSC3 mutation c.92G→C, p.G31A is a founder mutation causing severe pontocerebellar hypoplasia type 1 among the Czech Roma.

Authors:  Jaroslava Schwabova; Dana Safka Brozkova; Borivoj Petrak; Mahulena Mojzisova; Klara Pavlickova; Jana Haberlova; Lenka Mrazkova; Petra Hedvicakova; Ludmila Hornofova; Marie Kaluzova; Filip Fencl; Marcela Krutova; Josef Zamecnik; Pavel Seeman
Journal:  J Neurogenet       Date:  2013-07-25       Impact factor: 1.250

5.  Exclusion of the gene locus for spinal muscular atrophy on chromosome 5q in a family with infantile olivopontocerebellar atrophy (OPCA) and anterior horn cell degeneration.

Authors:  S Rudnik-Schöneborn; B Wirth; D Röhrig; H Saule; K Zerres
Journal:  Neuromuscul Disord       Date:  1995-01       Impact factor: 4.296

6.  Pontocerebellar hypoplasia type 1: clinical spectrum and relevance of EXOSC3 mutations.

Authors:  Sabine Rudnik-Schöneborn; Jan Senderek; Joanna C Jen; Gunnar Houge; Pavel Seeman; Alena Puchmajerová; Luitgard Graul-Neumann; Ulrich Seidel; Rudolf Korinthenberg; Janbernd Kirschner; Jürgen Seeger; Monique M Ryan; Francesco Muntoni; Maja Steinlin; Laszlo Sztriha; Jaume Colomer; Christoph Hübner; Knut Brockmann; Lionel Van Maldergem; Manuel Schiff; Andreas Holzinger; Peter Barth; William Reardon; Michael Yourshaw; Stanley F Nelson; Thomas Eggermann; Klaus Zerres
Journal:  Neurology       Date:  2013-01-02       Impact factor: 9.910

Review 7.  Classification, diagnosis and potential mechanisms in pontocerebellar hypoplasia.

Authors:  Yasmin Namavar; Peter G Barth; Bwee Tien Poll-The; Frank Baas
Journal:  Orphanet J Rare Dis       Date:  2011-07-12       Impact factor: 4.123

8.  Mutations in the RNA exosome component gene EXOSC3 cause pontocerebellar hypoplasia and spinal motor neuron degeneration.

Authors:  Jijun Wan; Michael Yourshaw; Hafsa Mamsa; Sabine Rudnik-Schöneborn; Manoj P Menezes; Ji Eun Hong; Derek W Leong; Jan Senderek; Michael S Salman; David Chitayat; Pavel Seeman; Arpad von Moers; Luitgard Graul-Neumann; Andrew J Kornberg; Manuel Castro-Gago; María-Jesús Sobrido; Masafumi Sanefuji; Perry B Shieh; Noriko Salamon; Ronald C Kim; Harry V Vinters; Zugen Chen; Klaus Zerres; Monique M Ryan; Stanley F Nelson; Joanna C Jen
Journal:  Nat Genet       Date:  2012-04-29       Impact factor: 38.330

9.  Clinical, neuroradiological and genetic findings in pontocerebellar hypoplasia.

Authors:  Yasmin Namavar; Peter G Barth; Paul R Kasher; Fred van Ruissen; Knut Brockmann; Günther Bernert; Karin Writzl; Karen Ventura; Edith Y Cheng; Donna M Ferriero; Lina Basel-Vanagaite; Veerle R C Eggens; Ingeborg Krägeloh-Mann; Linda De Meirleir; Mary King; John M Graham; Arpad von Moers; Nine Knoers; Laszlo Sztriha; Rudolf Korinthenberg; William B Dobyns; Frank Baas; Bwee Tien Poll-The
Journal:  Brain       Date:  2010-10-15       Impact factor: 15.255

10.  EXOSC3 mutations in pontocerebellar hypoplasia type 1: novel mutations and genotype-phenotype correlations.

Authors:  Veerle Rc Eggens; Peter G Barth; Jikke-Mien F Niermeijer; Jonathan N Berg; Niklas Darin; Abhijit Dixit; Joel Fluss; Nicola Foulds; Darren Fowler; Tibor Hortobágyi; Thomas Jacques; Mary D King; Periklis Makrythanasis; Adrienn Máté; James A R Nicoll; Declan O'Rourke; Sue Price; Andrew N Williams; Louise Wilson; Mohnish Suri; Laszlo Sztriha; Marit B Dijns-de Wissel; Mia T van Meegen; Fred van Ruissen; Eleonora Aronica; Dirk Troost; Charles Blm Majoie; Henk A Marquering; Bwee Tien Poll-Thé; Frank Baas
Journal:  Orphanet J Rare Dis       Date:  2014-02-13       Impact factor: 4.123

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.